|
1
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar
|
|
2
|
Feng M, Gao W, Wang R, Chen W, Man YG,
Figg WD, Wang XW, Dimitrov DS and Ho M: Therapeutically targeting
glypican-3 via a conformation-specific single-domain antibody in
hepatocellular carcinoma. Proc Natl Acad Sci USA. 110:E1083–E1091.
2013. View Article : Google Scholar :
|
|
3
|
Seth A and Watson DK: ETS transcription
factors and their emerging roles in human cancer. Eur J Cancer.
41:2462–2478. 2005. View Article : Google Scholar
|
|
4
|
Buggy Y, Maguire TM, McGreal G, McDermott
E, Hill AD, O'Higgins N and Duffy MJ: Overexpression of the Ets-1
transcription factor in human breast cancer. Br J Cancer.
91:1308–1315. 2004. View Article : Google Scholar :
|
|
5
|
Buggy Y, Maguire TM, McDermott E, Hill AD,
O'Higgins N and Duffy MJ: Ets2 transcription factor in normal and
neoplastic human breast tissue. Eur J Cancer. 42:485–491. 2006.
View Article : Google Scholar
|
|
6
|
Shintani S, Hamakawa H, Nakashiro K,
Shirota T, Hatori M, Tanaka M, Kuroshita Y and Kurokawa Y: Friend
leukaemia insertion (Fli)-1 is a prediction marker candidate for
radiotherapy resistant oral squamous cell carcinoma. Int J Oral
Maxillofac Surg. 39:1115–1119. 2010. View Article : Google Scholar
|
|
7
|
Ben-David Y, Giddens EB, Letwin K and
Bernstein A: Erythroleukemia induction by friend murine leukemia
virus: Insertional activation of a new member of the ets gene
family, Fli-1, closely linked to c-ets-1. Genes Dev. 5:908–918.
1991. View Article : Google Scholar
|
|
8
|
Truong AH and Ben-David Y: The role of
Fli-1 in normal cell function and malignant transformation.
Oncogene. 19:6482–6489. 2000. View Article : Google Scholar
|
|
9
|
Kawada H, Ito T, Pharr PN, Spyropoulos DD,
Watson DK and Ogawa M: Defective megakaryopoiesis and abnormal
erythroid development in Fli-1 gene-targeted mice. Int J Hematol.
73:463–468. 2001. View Article : Google Scholar
|
|
10
|
Spyropoulos DD, Pharr PN, Lavenburg KR,
Jackers P, Papas TS, Ogawa M and Watson DK: Hemorrhage, impaired
hematopoiesis, and lethality in mouse embryos carrying a targeted
disruption of the Fli1 transcription factor. Mol Cell Biol.
20:5643–5652. 2000. View Article : Google Scholar :
|
|
11
|
Song W, Li W, Li L, Zhang S, Yan X, Wen X,
Zhang X, Tian H, Li A, Hu JF and Cui J: Friend leukemia virus
integration 1 activates the Rho GTPase pathway and is associated
with metastasis in breast cancer. Oncotarget. 6:23764–23775. 2015.
View Article : Google Scholar :
|
|
12
|
Torlakovic EE, Slipicevic A, Flørenes VA,
Chibbar R, DeCoteau JF and Bilalovic N: Fli-1 expression in
malignant melanoma. Histol Histopathol. 23:1309–1314. 2008.
|
|
13
|
Ladanyi M: EWS-FLI1 and Ewing's sarcoma:
Recent molecular data and new insights. Cancer Biol Ther.
1:330–336. 2002. View Article : Google Scholar
|
|
14
|
Riggi N, Suvà ML, Suvà D, Cironi L,
Provero P, Tercier S, Joseph JM, Stehle JC, Baumer K, Kindler V and
Stamenkovic I: EWS-FLI-1 expression triggers a Ewing's sarcoma
initiation program in primary human mesenchymal stem cells. Cancer
Res. 68:2176–2185. 2008. View Article : Google Scholar
|
|
15
|
Liang X, Shi D, Yun J, Mao Y, Ouyang P, Su
Z, Fu J, Hou J, Deng W and Xie F: Friend leukemia virus integration
1 expression has prognostic significance in nasopharyngeal
carcinoma. Transl Oncol. 7:493–502. 2014. View Article : Google Scholar :
|
|
16
|
Jia D, Yan M, Wang X, Hao X, Liang L, Liu
L, Kong H, He X, Li J and Yao M: Development of a highly metastatic
model that reveals a crucial role of fibronectin in lung cancer
cell migration and invasion. BMC Cancer. 10:3642010. View Article : Google Scholar :
|
|
17
|
Asano Y, Stawski L, Hant F, Highland K,
Silver R, Szalai G, Watson DK and Trojanowska M: Endothelial Fli1
deficiency impairs vascular homeostasis: A role in scleroderma
vasculopathy. Am J Pathol. 176:1983–1998. 2010. View Article : Google Scholar :
|
|
18
|
Zhang J, Guo H, Zhang H, Wang H, Qian G,
Fan X, Hoffman AR, Hu JF and Ge S: Putative tumor suppressor
miR-145 inhibits colon cancer cell growth by targeting oncogene
Friend leukemia virus integration 1 gene. Cancer. 117:86–95. 2011.
View Article : Google Scholar
|
|
19
|
Wu P, Liang J, Yu F, Zhou Z, Tang J and Li
K: MiR-145 promotes osteosarcoma growth by reducing expression of
the transcription factor friend leukemia virus integration 1.
Oncotarget. 7:42241–42251. 2016. View Article : Google Scholar :
|
|
20
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: Diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View
Article : Google Scholar
|
|
21
|
Kleiner DE and Stetler-Stevenson WG:
Matrix metalloproteinases and metastasis. Cancer Chemother
Pharmacol. 43 Suppl:S42–S51. 1999. View Article : Google Scholar
|
|
22
|
Curran S and Murray GI: Matrix
metalloproteinases in tumour invasion and metastasis. J Pathol.
189:300–308. 1999. View Article : Google Scholar
|
|
23
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar :
|
|
24
|
Itoh T, Tanioka M, Yoshida H, Yoshioka T,
Nishimoto H and Itohara S: Reduced angiogenesis and tumor
progression in gelatinase A-deficient mice. Cancer Res.
58:1048–1051. 1998.
|
|
25
|
Ogasawara S, Yano H, Momosaki S, Nishida
N, Takemoto Y, Kojiro S and Kojiro M: Expression of matrix
metalloproteinases (MMPs) in cultured hepatocellular carcinoma
(HCC) cells and surgically resected HCC tissues. Oncol Rep.
13:1043–1048. 2005.
|
|
26
|
Giannelli G, Bergamini C, Marinosci F,
Fransvea E, Quaranta M, Lupo L, Schiraldi O and Antonaci S:
Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular
carcinoma. Int J Cancer. 97:425–431. 2002. View Article : Google Scholar
|
